<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39296584</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2589-5370</ISSN><JournalIssue CitedMedium="Internet"><Volume>76</Volume><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>EClinicalMedicine</Title><ISOAbbreviation>EClinicalMedicine</ISOAbbreviation></Journal><ArticleTitle>Characteristics and predictors of Long Covid in children: a 3-year prospective cohort study.</ArticleTitle><Pagination><StartPage>102815</StartPage><MedlinePgn>102815</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102815</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eclinm.2024.102815</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Children can develop Long Covid, however long term outcomes and their predictors are poorly described in these patients. The primary aim is to describe characteristics and predictors of Long Covid in children assessed in-clinics up to 36 months post-SARS-CoV-2 infection, as well as investigate the role of vaccines in preventing Long Covid, risk of reinfections and development of autoimmune diseases.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Children aged 0-18 years old with confirmed SARS-CoV-2 infection were invited for a prospective follow-up assessment at a peadiatric post-covid clinic in Rome, Italy, at serial intervals (3-, 6-, 12-, 18-, 24- and 36-months post-infection onset, between 01/02/2020 and 28/02/2024). Long Covid was defined as persistence of otherwise unexplained symptoms for at least three months after initial infection.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="UNASSIGNED">1319 patients were initially included, 1296 reached the 3 months follow-up or more. Of the patients who underwent multiple follow-ups, 23.2% (301), 169 (13.2%), 89 (7.9%), 67 (6.1%), 47 (7.1%) were diagnosed with Long Covid at 3-6-12-18-24 months, respectively For the primary outcome of Long Covid at three months, age &gt;12 years (P&#xa0;&lt;&#xa0;0.001, OR 11.33, 95% CI 4.2; 15.15), comorbidities (P&#xa0;=&#xa0;0.008, OR 1.83, 95% CI 1.06; 2.44), being infected with original variants (P&#xa0;&lt;&#xa0;0.001, OR 4.77, 95% CI 2.46; 14.47), female sex (P&#xa0;&lt;&#xa0;0.001, OR 1.62, 95% CI 1.02; 1.89) were statistically significant risk factors. Age &gt;12 years (P&#xa0;=&#xa0;0.002, OR 9.37, 95% CI 1.58; 8.64), and infection with original (P&#xa0;=&#xa0;0.012, OR 3.52, 95% CI 1.32; 8.64) and alfa (P&#xa0;&lt;&#xa0;0.001, OR 4.09, 95% CI 2.01; 8.3) SARS-CoV-2 variants remained statistically significant risk factors for Long Covid duration for at least 18 months. Vaccination was associated with a lower risk of long covid at 3, 6 and 12 months for older children and a lower risk of reinfections. Being infected with the original SARS-CoV-2 variant was associated with a higher risk of new-onset autoimmune diseases ((P&#xa0;=&#xa0;0.035, 95% CI 1.12; 2.4). One patient was diagnosed with Long Covid after a re-infection.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="UNASSIGNED">This is the longest follow-up study of children with SARS-CoV-2 infection, showing a significant and long-lasting burden of Long Covid in the pediatric population. Our findings highlight the urgent need of investing in pediatric Long Covid in order to find effective diagnostic and therapeutic approaches, as well can inform preventive strategies in case of future pandemics.</AbstractText><AbstractText Label="FUNDING" NlmCategory="UNASSIGNED">This study has been funde by Pfizer non-competitive grant, granted to DB (#65925795).</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Camporesi</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pediatric Anesthesia and Intensive Care, V. Buzzi Children's Hospital, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morello</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>La Rocca</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medicine ans Surgery, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zampino</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vezzulli</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, University of Milano, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munblit</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Care for Long Term Conditions Division, Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raffaelli</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>UOC Malattie Infettive - Dipartimento Scienze Mediche e Chirurgiche -. Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valentini</LastName><ForeName>Piero</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buonsenso</LastName><ForeName>Danilo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro di Salute Globale, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Area Pediatrica, Dipartimento di Scienze della Vita e Sanit&#xe0; Pubblica, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EClinicalMedicine</MedlineTA><NlmUniqueID>101733727</NlmUniqueID><ISSNLinking>2589-5370</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 vaccination</Keyword><Keyword MajorTopicYN="N">Children</Keyword><Keyword MajorTopicYN="N">Long covid</Keyword><Keyword MajorTopicYN="N">Post-covid condition</Keyword><Keyword MajorTopicYN="N">Risk factors</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 variants</Keyword></KeywordList><CoiStatement>DB was been granted a non-competitive grant from Pfizer to study Long Covid in children, and has won a grant to study mRNA profile in children with Long Covid from Roche Italia and ESPID. DB has participated in educational peer-to-peer programs on Long Covid organized by Pfizer and has participated as invited speaker and a sponsored session of COVID-19 vaccines in children at the ESPID conference in&#xa0;2022.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>19</Day><Hour>5</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39296584</ArticleId><ArticleId IdType="pmc">PMC11408803</ArticleId><ArticleId IdType="doi">10.1016/j.eclinm.2024.102815</ArticleId><ArticleId IdType="pii">S2589-5370(24)00394-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>https://www.who.int/publications/i/item/WHO-2019-nCoV-Post-COVID-19-condition-CA-Clinical-case-definition-2023-1</Citation></Reference><Reference><Citation>Morello R., Mariani F., Mastrantoni L., et al. Risk factors for post-COVID-19 condition (Long Covid) in children: a prospective cohort study. EClinicalMedicine. 2023;59 doi: 10.1016/j.eclinm.2023.101961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.101961</ArticleId><ArticleId IdType="pmc">PMC10101848</ArticleId><ArticleId IdType="pubmed">37073325</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia-Hasler C., Br&#xfc;ningk S.C., Hoch T., et al. Persistent complement dysregulation with signs of thromboinflammation in active Long Covid. Science. 2024;383(6680) doi: 10.1126/science.adg7942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.adg7942</ArticleId><ArticleId IdType="pubmed">38236961</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin K., Peluso M.J., Luo X., et al. Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2. Nat Immunol. 2024;25(2):218&#x2013;225. doi: 10.1038/s41590-023-01724-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01724-6</ArticleId><ArticleId IdType="pmc">PMC10834368</ArticleId><ArticleId IdType="pubmed">38212464</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil B.A., Elemam N.M., Maghazachi A.A. Chemokines and chemokine receptors during COVID-19 infection. Comput Struct Biotechnol J. 2021;19:976&#x2013;988. doi: 10.1016/j.csbj.2021.01.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csbj.2021.01.034</ArticleId><ArticleId IdType="pmc">PMC7859556</ArticleId><ArticleId IdType="pubmed">33558827</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S., Lee G.M., Razzaghi H., et al. Clinical features and burden of postacute sequelae of SARS-CoV-2 infection in children and adolescents. JAMA Pediatr. 2022;176(10):1000&#x2013;1009. doi: 10.1001/jamapediatrics.2022.2800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2022.2800</ArticleId><ArticleId IdType="pmc">PMC9396470</ArticleId><ArticleId IdType="pubmed">35994282</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma C., Bayry J. High risk of autoimmune diseases after COVID-19. Nat Rev Rheumatol. 2023;19(7):399&#x2013;400. doi: 10.1038/s41584-023-00964-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-023-00964-y</ArticleId><ArticleId IdType="pmc">PMC10096101</ArticleId><ArticleId IdType="pubmed">37046064</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto Pereira S.M., Nugawela M.D., Stephenson T., et al. Post-Covid-19 condition (Long Covid) in children and young people 12 months after infection or reinfection with the Omicron variant: a prospective observational study. Sci Rep. 2024;14(1):9957. doi: 10.1038/s41598-024-60372-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-60372-4</ArticleId><ArticleId IdType="pmc">PMC11063180</ArticleId><ArticleId IdType="pubmed">38693285</ArticleId></ArticleIdList></Reference><Reference><Citation>Foret-Bruno P., Shafran R., Stephenson T., et al. Prevalence and co-occurrence of cognitive impairment in children and young people up to 12-months post infection with SARS-CoV-2 (Omicron variant) Brain Behav Immun. 2024;119:989&#x2013;994. doi: 10.1016/j.bbi.2024.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2024.05.001</ArticleId><ArticleId IdType="pubmed">38735404</ArticleId></ArticleIdList></Reference><Reference><Citation>https://www.epicentro.iss.it/coronavirus/sars-cov-2-monitoraggio-varianti</Citation></Reference><Reference><Citation>Stephenson T., Allin B., Nugawela M.D., et al. Long COVID (post-COVID-19 condition) in children: a modified Delphi process. Arch Dis Child. 2022;107(7):674&#x2013;680. doi: 10.1136/archdischild-2021-323624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2021-323624</ArticleId><ArticleId IdType="pmc">PMC8983414</ArticleId><ArticleId IdType="pubmed">35365499</ArticleId></ArticleIdList></Reference><Reference><Citation>Seaman S.R., White I.R. Review of inverse probability weighting for dealing with missing data. Stat Methods Med Res. 2013;22(3):278&#x2013;295. doi: 10.1177/0962280210395740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280210395740</ArticleId><ArticleId IdType="pubmed">21220355</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Morello R., Mariani F., et al. Risk of long Covid in children infected with Omicron or pre-Omicron SARS-CoV-2 variants. Acta Paediatr. 2023;112(6):1284&#x2013;1286. doi: 10.1111/apa.16764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.16764</ArticleId><ArticleId IdType="pubmed">36938946</ArticleId></ArticleIdList></Reference><Reference><Citation>Surmachevska N., Tiwari V. StatPearls [internet]. Treasure island (FL) StatPearls Publishing; 2023. Corticosteroid induced myopathy. 2023.</Citation><ArticleIdList><ArticleId IdType="pubmed">32491663</ArticleId></ArticleIdList></Reference><Reference><Citation>Pazukhina E., Andreeva M., Spiridonova E., et al. Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID) BMC Med. 2022;20:244. doi: 10.1186/s12916-022-02448-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02448-4</ArticleId><ArticleId IdType="pmc">PMC9257572</ArticleId><ArticleId IdType="pubmed">35794549</ArticleId></ArticleIdList></Reference><Reference><Citation>Martino G.P., Benfaremo D., Bitti G., et al. 6 and 12 month outcomes in patients following COVID-19-related hospitalization: a prospective monocentric study. Intern Emerg Med. 2022;17(6):1641&#x2013;1649. doi: 10.1007/s11739-022-02979-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-022-02979-x</ArticleId><ArticleId IdType="pmc">PMC8994524</ArticleId><ArticleId IdType="pubmed">35397762</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariani C., Borgonovo F., Capetti A.F., et al. Persistence of Long-COVID symptoms in a heterogenous prospective cohort. J&#xa0;Infect. 2022;84(5):722&#x2013;746. doi: 10.1016/j.jinf.2022.01.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.01.024</ArticleId><ArticleId IdType="pmc">PMC8783396</ArticleId><ArticleId IdType="pubmed">35077770</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V.T., Porcher R., Pane I., Ravaud P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat Commun. 2022;13(1):1812. doi: 10.1038/s41467-022-29513-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29513-z</ArticleId><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Nemati M., Nemati H. &#x2018;Long COVID': symptom persistence in children hospitalised for COVID-19. J&#xa0;Paediatr Child Health. 2022;58(10):1836&#x2013;1840. doi: 10.1111/jpc.16120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpc.16120</ArticleId><ArticleId IdType="pmc">PMC9349535</ArticleId><ArticleId IdType="pubmed">35851732</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L., Holm M., Knudsen M., Ellermann-Eriksen S., Hagstroem S. Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study. Eur J Pediatr. 2022 Apr;181(4):1597&#x2013;1607. doi: 10.1007/s00431-021-04345-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04345-z</ArticleId><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Di Giuda D., Sigfrid L., et al. Evidence of lung perfusion defects and ongoing inflammation in an adolescent with post-acute sequelae of SARS-CoV-2 infection. Lancet Child Adolesc Health. 2021;5(9):677&#x2013;680. doi: 10.1016/S2352-4642(21)00196-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00196-6</ArticleId><ArticleId IdType="pmc">PMC8324416</ArticleId><ArticleId IdType="pubmed">34339624</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzuto D.A., Buonsenso D., Morello R., et al. Lung perfusion assessment in children with long-COVID: a pilot study. Pediatr Pulmonol. 2023;58(7):2059&#x2013;2067. doi: 10.1002/ppul.26432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.26432</ArticleId><ArticleId IdType="pubmed">37097045</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocciolillo F., Di Giuda D., Morello R., De Rose C., Valentini P., Buonsenso D. Orbito-frontal Cortex hypometabolism in children with post-COVID condition (long COVID): a preliminary experience. Pediatr Infect Dis J. 2022;41(8):663&#x2013;665. doi: 10.1097/INF.0000000000003578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003578</ArticleId><ArticleId IdType="pmc">PMC9281418</ArticleId><ArticleId IdType="pubmed">35839175</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocciolillo F., Chieffo D.P.R., Giordano A., et al. Case report: post-COVID new-onset neurocognitive decline with bilateral mesial-temporal hypometabolism in two previously healthy sisters. Front Pediatr. 2023;11 doi: 10.3389/fped.2023.1165072.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2023.1165072</ArticleId><ArticleId IdType="pmc">PMC10251436</ArticleId><ArticleId IdType="pubmed">37303754</ArticleId></ArticleIdList></Reference><Reference><Citation>Delogu A.B., Aliberti C., Birritella L., et al. Autonomic cardiac function in children and adolescents with long COVID: a case-controlled study. Eur J Pediatr. 2024 doi: 10.1007/s00431-024-05503-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-024-05503-9</ArticleId><ArticleId IdType="pmc">PMC11035407</ArticleId><ArticleId IdType="pubmed">38446228</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldi F., De Rose C., Mariani F., et al. Cardiopulmonary exercise testing in children with long COVID: a case-controlled study. Pediatr Infect Dis J. 2024;43(8):795&#x2013;802. doi: 10.1097/INF.0000000000004371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000004371</ArticleId><ArticleId IdType="pmc">PMC11250093</ArticleId><ArticleId IdType="pubmed">38713816</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Sorrentino S., Ferretti A., et al. Circulating activated platelets in children with long covid: a case-controlled preliminary observation. Pediatr Infect Dis J. 2024;15 doi: 10.1097/INF.0000000000004470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000004470</ArticleId><ArticleId IdType="pubmed">39018475</ArticleId></ArticleIdList></Reference><Reference><Citation>Menezes S.M., Jamoulle M., Carletto M.P., et al. Blood transcriptomic analyses reveal persistent SARS-CoV-2 RNA and candidate biomarkers in post-COVID-19 condition. Lancet Microbe. 2024;S2666-S5247(24) doi: 10.1016/S2666-5247(24)00055-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(24)00055-7</ArticleId><ArticleId IdType="pubmed">38677304</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Martino L., Morello R., Mariani F., Fearnley K., Valentini P. Viral persistence in children infected with SARS-CoV-2: current evidence and future research strategies. Lancet Microbe. 2023;4(9):e745&#x2013;e756. doi: 10.1016/S2666-5247(23)00115-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(23)00115-5</ArticleId><ArticleId IdType="pmc">PMC10292824</ArticleId><ArticleId IdType="pubmed">37385286</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J., Wood J., Jaycox J.R., et al. Distinguishing features of long COVID identified through immune profiling. Nature. 2023 Nov;623(7985):139&#x2013;148. doi: 10.1038/s41586-023-06651-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Valentini P., De Rose C., et al. Recovering or persisting: the immunopathological features of SARS-CoV-2 infection in children. J&#xa0;Clin Med. 2022;11(15):4363. doi: 10.3390/jcm11154363.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11154363</ArticleId><ArticleId IdType="pmc">PMC9369242</ArticleId><ArticleId IdType="pubmed">35955979</ArticleId></ArticleIdList></Reference><Reference><Citation>https://www.science.org/content/article/antibodies-long-covid-patients-prompt-symptoms-mice#:&#x223c;:text=But%20on%20a%20test%20of,medRxiv%20preprint%20on%2019%20June</Citation></Reference><Reference><Citation>Buonsenso D., Tantisira K.G. Long COVID and SARS-CoV-2 persistence: new answers, more questions. Lancet Infect Dis. 2024;S1473-S3099(24):00216. doi: 10.1016/S1473-3099(24)00216-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(24)00216-0</ArticleId><ArticleId IdType="pubmed">38663424</ArticleId></ArticleIdList></Reference><Reference><Citation>Seylanova N., Chernyavskaya A., Degtyareva N., et al. Core outcome measurement set for research and clinical practice in post-COVID-19 condition (long COVID) in children and young people: an international Delphi consensus study "PC-COS Children". Eur Respir J. 2024;63(3) doi: 10.1183/13993003.01761-2023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01761-2023</ArticleId><ArticleId IdType="pmc">PMC10938351</ArticleId><ArticleId IdType="pubmed">38359962</ArticleId></ArticleIdList></Reference><Reference><Citation>Brackel C.L.H., Noij L.C.E., Vijverberg S.J.H., et al. International care programs for pediatric post-COVID condition (long COVID) and the way forward. Pediatr Res. 2024;29 doi: 10.1038/s41390-023-03015-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41390-023-03015-0</ArticleId><ArticleId IdType="pubmed">38287106</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Pujol J.C., Spector T.D., Ourselin S., Steves C.J. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399(10343):2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Messiah S.E., Hao T., DeSantis S.M., et al. Comparison of persistent symptoms following SARS-CoV-2 infection by antibody status in nonhospitalized children and adolescents. Pediatr Infect Dis J. 2022;41(10):e409&#x2013;e417. doi: 10.1097/INF.0000000000003653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003653</ArticleId><ArticleId IdType="pubmed">35939608</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnusson K., Kristoffersen D.T., Dell'Isola A., et al. Post-covid medical complaints following infection with SARS-CoV-2 Omicron vs Delta variants. Nat Commun. 2022;13:7363. doi: 10.1038/s41467-022-35240-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-35240-2</ArticleId><ArticleId IdType="pmc">PMC9709355</ArticleId><ArticleId IdType="pubmed">36450749</ArticleId></ArticleIdList></Reference><Reference><Citation>Morioka S., Tsuzuki S., Suzuki M., et al. Post COVID-19 condition of the Omicron variant of SARS-CoV-2. J&#xa0;Infect Chemother. 2022;28(11):1546&#x2013;1551. doi: 10.1016/j.jiac.2022.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiac.2022.08.007</ArticleId><ArticleId IdType="pmc">PMC9365517</ArticleId><ArticleId IdType="pubmed">35963600</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Sillett R., Zhu L., et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatr. 2022;9(10):815&#x2013;827. doi: 10.1016/S2215-0366(22)00260-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(22)00260-7</ArticleId><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>https://www.idsociety.org/covid-19-real-time-learning-network/therapeutics-and-interventions/faq-long-covid-and-covid-19-reinfection/#/+/0/publishedDate_na_dt/desc/</Citation></Reference><Reference><Citation>Razzaghi H., Forrest C.B., Hirabayashi K., et al. RECOVER CONSORTIUM. Vaccine effectiveness against long COVID in children. Pediatrics. 2024;153(4) doi: 10.1542/peds.2023-064446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2023-064446</ArticleId><ArticleId IdType="pmc">PMC10979300</ArticleId><ArticleId IdType="pubmed">38225804</ArticleId></ArticleIdList></Reference><Reference><Citation>Marra A.R., Kobayashi T., Callado G.Y., et al. The effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions: a systematic literature review and meta-analysis of the latest research. Antimicrob Steward Healthc Epidemiol. 2023;3(1) doi: 10.1017/ash.2023.447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ash.2023.447</ArticleId><ArticleId IdType="pmc">PMC10644173</ArticleId><ArticleId IdType="pubmed">38028898</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Cusenza F., Passadore L., Bonanno F., De Guido C., Esposito S. Duration of immunity to SARS-CoV-2 in children after natural infection or vaccination in the omicron and pre-omicron era: a systematic review of clinical and immunological studies. Front Immunol. 2023;13 doi: 10.3389/fimmu.2022.1024924.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1024924</ArticleId><ArticleId IdType="pmc">PMC9874918</ArticleId><ArticleId IdType="pubmed">36713374</ArticleId></ArticleIdList></Reference><Reference><Citation>Mensah A.A., Campbell H., Stowe J., et al. Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study between January, 2020, and July, 2021, in England. Lancet Child Adolesc Health. 2022;6(6):384&#x2013;392. doi: 10.1016/S2352-4642(22)00059-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00059-1</ArticleId><ArticleId IdType="pmc">PMC8959472</ArticleId><ArticleId IdType="pubmed">35358491</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhaddad F., Abdulkareem A., Alsharrah D., et al. Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait. BMJ Open. 2022;12(6) doi: 10.1136/bmjopen-2021-056371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-056371</ArticleId><ArticleId IdType="pmc">PMC9240452</ArticleId><ArticleId IdType="pubmed">35768102</ArticleId></ArticleIdList></Reference><Reference><Citation>Medic S., Anastassopoulou C., Lozanov-Crvenkovic Z., et al. Incidence, risk, and severity of SARS-CoV-2 reinfections in children and adolescents between March 2020 and July 2022 in Serbia. JAMA Netw Open. 2023;6(2) doi: 10.1001/jamanetworkopen.2022.55779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.55779</ArticleId><ArticleId IdType="pmc">PMC9926322</ArticleId><ArticleId IdType="pubmed">36780157</ArticleId></ArticleIdList></Reference><Reference><Citation>Erba&#x15f; &#x130;.C., Kele&#x15f; Y.E., Erdeniz E.H., et al. Evaluation of possible COVID-19 reinfection in children: a multicenter clinical study. Arch Pediatr. 2023;30(3):187&#x2013;191. doi: 10.1016/j.arcped.2023.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcped.2023.01.008</ArticleId><ArticleId IdType="pmc">PMC9902289</ArticleId><ArticleId IdType="pubmed">36804354</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Perramon A., Catal&#xe0; M., et al. Multisystem inflammatory syndrome in children in Western countries? Decreasing incidence as the pandemic Progresses?: an observational multicenter international cross-sectional study. Pediatr Infect Dis J. 2022;41(12):989&#x2013;993. doi: 10.1097/INF.0000000000003713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003713</ArticleId><ArticleId IdType="pmc">PMC9645445</ArticleId><ArticleId IdType="pubmed">36102705</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghali A., Richa P., Lacout C., et al. Epidemiological and clinical factors associated with post-exertional malaise severity in patients with myalgic encephalomyelitis/chronic fatigue syndrome. J&#xa0;Transl Med. 2020;18(1):246. doi: 10.1186/s12967-020-02419-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02419-4</ArticleId><ArticleId IdType="pmc">PMC7309998</ArticleId><ArticleId IdType="pubmed">32571354</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M.S., Lee H., Lee S.W., et al. Long-term autoimmune inflammatory Rheumatic outcomes of COVID-19 : a Binational cohort study. Ann Intern Med. 2024;177(3):291&#x2013;302. doi: 10.7326/M23-1831.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M23-1831</ArticleId><ArticleId IdType="pubmed">38437702</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim S.H., Ju H.J., Han J.H., et al. Autoimmune and Autoinflammatory connective tissue disorders following COVID-19. JAMA Netw Open. 2023;6(10) doi: 10.1001/jamanetworkopen.2023.36120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.36120</ArticleId><ArticleId IdType="pmc">PMC10559181</ArticleId><ArticleId IdType="pubmed">37801317</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson C. As COVID-19 cases rose, so did diabetes - no one knows why. Nature. 2023;619(7971):677&#x2013;678. doi: 10.1038/d41586-023-02322-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-023-02322-0</ArticleId><ArticleId IdType="pubmed">37474773</ArticleId></ArticleIdList></Reference><Reference><Citation>Das S., Parul S.M. Autoimmune diseases post-COVID 19 infection in children in intensive care unit: a case series. Int J Rheum Dis. 2023;26(11):2288&#x2013;2293. doi: 10.1111/1756-185X.14724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.14724</ArticleId><ArticleId IdType="pubmed">37157177</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D. A&#xa0;call to invest in immunological determinants of pediatric post-COVID conditions: insights from a post-COVID pANCA+ diffuse alveolar hemorrhage in an adolescent. Pediatr Pulmonol. 2022;57(11):2861&#x2013;2862. doi: 10.1002/ppul.26097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.26097</ArticleId><ArticleId IdType="pmc">PMC9538831</ArticleId><ArticleId IdType="pubmed">35931658</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon T.A., Harikrishnan G.P., Kawabata H., Singhal S., Brunner H.I., Lovell D.J. Prevalence of co-existing autoimmune disease in juvenile idiopathic arthritis: a cross-sectional study. Pediatr Rheumatol Online J. 2020;18(1):43. doi: 10.1186/s12969-020-00426-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12969-020-00426-9</ArticleId><ArticleId IdType="pmc">PMC7275412</ArticleId><ArticleId IdType="pubmed">32503658</ArticleId></ArticleIdList></Reference><Reference><Citation>https://celiac.org/about-the-foundation/featured-news/2020/02/incidence-of-celiac-disease-steadily-increasing/</Citation></Reference><Reference><Citation>Fang Xy, Ye D.Q. In: Progress in China epidemiology. Ye D.Q., editor. Springer; Singapore: 2022. Research advances in epidemiology of autoimmune diseases in China.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-19-2199-5_17</ArticleId></ArticleIdList></Reference><Reference><Citation>Konvinse K., Bruiners N., Ukey R., Horton D., Gennaro M., Utz P. High prevalence of autoantibodies in children after COVID-19 infection of differing levels of severity. J&#xa0;Allergy Clin Immunol. 2022;149(3 Suppl) doi: 10.1016/j.jaci.2022.12.794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2022.12.794</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Notarte K.I., Peligro P.J., et al. Long-COVID symptoms in individuals infected with different SARS-CoV-2 variants of concern: a systematic review of the literature. Viruses. 2022;14(12):2629. doi: 10.3390/v14122629.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14122629</ArticleId><ArticleId IdType="pmc">PMC9785120</ArticleId><ArticleId IdType="pubmed">36560633</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., de Oliveira M.H.S., Peligro P.J., et al. Age, sex and previous comorbidities as risk factors not associated with SARS-CoV-2 infection for long COVID-19: a systematic review and meta-analysis. J&#xa0;Clin Med. 2022;11(24):7314. doi: 10.3390/jcm11247314.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11247314</ArticleId><ArticleId IdType="pmc">PMC9787827</ArticleId><ArticleId IdType="pubmed">36555931</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Pe&#xf1;as C., Notarte K.I., Macasaet R., et al. Persistence of post-COVID symptoms in the general population two years after SARS-CoV-2 infection: a systematic review and meta-analysis. J&#xa0;Infect. 2024;88(2):77&#x2013;88. doi: 10.1016/j.jinf.2023.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2023.12.004</ArticleId><ArticleId IdType="pubmed">38101521</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Torres-Macho J., Catahay J.A., et al. Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review. Infection. 2024;52(1):43&#x2013;58. doi: 10.1007/s15010-023-02154-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-023-02154-0</ArticleId><ArticleId IdType="pubmed">38113020</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q., Zhang B., Tong J., et al. Real-world effectiveness and causal mediation study of BNT162b2 on long COVID risks in children and adolescents. medRxiv. 2024 doi: 10.1101/2024.02.19.24302823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.02.19.24302823</ArticleId></ArticleIdList></Reference><Reference><Citation>Oeser C., Whitaker H., Borrow R., et al. Following the Omicron wave, the majority of children in England have evidence of previous COVID infection. J&#xa0;Infect. 2022;S0163-S4453(22):00701. doi: 10.1016/j.jinf.2022.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.12.012</ArticleId><ArticleId IdType="pmc">PMC9759455</ArticleId><ArticleId IdType="pubmed">36543312</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>